Volcano, Lumen align for thrombus aspiration catheter distribution
Volcano, a developer of products for the diagnosis and treatment of coronary and peripheral artery disease, has formed an exclusive worldwide distribution agreement to initiate the formal launch of the Xtract thrombus aspiration catheter, manufactured by the Plymouth, Minn-based Lumen Biomedical.
The Xtract thrombus aspiration catheter has been cleared by the FDA and is CE marked for use in coronary vessels, as well as some peripheral vascular applications. Volcano said that the device incorporates three design attributes, including a single lumen design to maximize cross-sectional area, and in turn, thrombus suction; a circular, right angle tip for close-up access to clots; and a curved, directional tip to enable sweep of the vessel.
The Xtract thrombus aspiration catheter is available for sale in the U.S. and Europe, according to the San Diego-based Volcano.
The Xtract thrombus aspiration catheter has been cleared by the FDA and is CE marked for use in coronary vessels, as well as some peripheral vascular applications. Volcano said that the device incorporates three design attributes, including a single lumen design to maximize cross-sectional area, and in turn, thrombus suction; a circular, right angle tip for close-up access to clots; and a curved, directional tip to enable sweep of the vessel.
The Xtract thrombus aspiration catheter is available for sale in the U.S. and Europe, according to the San Diego-based Volcano.